We are live on
!
Find out more
AC
Aristides Capital Portfolio holdings
AUM
$462M
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+9.88%
1 Year Est. Return
+28.94%
3 Year Est. Return
+109.78%
5 Year Est. Return
+150.66%
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$32M
(-9%)
Cap. Flow
-$63.2M
Cap. Flow
% of AUM
-19.62%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
323
New
60
Increased
28
Reduced
53
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.1M |
| 2 |
Dollar General
DG
|
+$1.64M |
| 3 |
PayPal
PYPL
|
+$1.27M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$1.19M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$9.18M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.47M |
| 3 |
Jackson Financial
JXN
|
+$2.45M |
| 4 |
Leidos
LDOS
|
+$2.04M |
| 5 |
ESAB
ESAB
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Industrials | 7.49% |
| 4 | Communication Services | 7.27% |
| 5 | Financials | 6.25% |
Similar funds
PRCP
PC
GLAM
NG
SWMG
SHWM
CPIM
HSA
Aristides Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Aristides Capital held 323 positions worth $322M, down 9% from $354M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Aristides Capital withdrew a net $63.2M in Q3 2024, closing 85 positions and reducing 53 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $9.18M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Aristides Capital opened a new position in Dollar General worth $1.27M.
- Aristides Capital's largest Q3 2024 buy was Dollar General: 15,000 shares worth $1.27M.
- Aristides Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $19.1M increase.
- Aristides Capital's biggest Q3 2024 reduction was Jackson Financial, cutting an estimated $2.45M.
- Aristides Capital fully exited iShares Biotechnology ETF in Q3 2024, selling an estimated $9.18M.
- Aristides Capital's ten largest holdings make up 44% of its $322M portfolio in Q3 2024.
- Aristides Capital opened 60 new positions and closed 85 in Q3 2024.
- Aristides Capital's portfolio value fell 9% quarter-over-quarter to $322M.
Based on Aristides Capital's 13F filing for Q3 2024, filed 14 Nov 2024.